Find Camphor manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

60RELATED EXCIPIENT COMPANIES

113EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 76-22-2, 2-camphanone, Dl-camphor, (+/-)-camphor, 2-bornanone, 1,7,7-trimethylbicyclo[2.2.1]heptan-2-one
Molecular Formula
C10H16O
Molecular Weight
152.23  g/mol
InChI Key
DSSYKIVIOFKYAU-UHFFFAOYSA-N

Camphor
A bicyclic monoterpene ketone found widely in plants, especially CINNAMOMUM CAMPHORA. It is used topically as a skin antipruritic and as an anti-infective agent.
1 2D Structure

Camphor

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1,7,7-trimethylbicyclo[2.2.1]heptan-2-one
2.1.2 InChI
InChI=1S/C10H16O/c1-9(2)7-4-5-10(9,3)8(11)6-7/h7H,4-6H2,1-3H3
2.1.3 InChI Key
DSSYKIVIOFKYAU-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1(C2CCC1(C(=O)C2)C)C
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Camphor, (+-)-isomer

2. Camphor, (1r)-isomer

3. Camphor, (1s)-isomer

2.2.2 Depositor-Supplied Synonyms

1. 76-22-2

2. 2-camphanone

3. Dl-camphor

4. (+/-)-camphor

5. 2-bornanone

6. 1,7,7-trimethylbicyclo[2.2.1]heptan-2-one

7. (+)-camphor

8. Bornan-2-one

9. Root Bark Oil

10. Kampfer

11. 21368-68-3

12. Spirit Of Camphor

13. 2-camphonone

14. Gum Camphor

15. 464-48-2

16. L-(-)-camphor

17. 1,7,7-trimethylnorcamphor

18. Alphanon

19. 1,7,7-trimethylbicyclo[2.2.1]-2-heptanone

20. D-(+)-camphor

21. 2-keto-1,7,7-trimethylnorcamphane

22. Formosa Camphor

23. Laurel Camphor

24. Matricaria Camphor

25. Camphor, Synthetic

26. 4,7,7-trimethylbicyclo[2.2.1]heptan-3-one

27. Bornane, 2-oxo-

28. Camphor (synthetic)

29. Huile De Camphre

30. Chebi:36773

31. 2-kamfanon

32. Bicyclo[2.2.1]heptan-2-one, 1,7,7-trimethyl-

33. Dl-bornan-2-one

34. (-)-alcanfor

35. Norcamphor, 1,7,7-trimethyl-

36. Camphor, (1r,4r)-(+)-

37. Synthetic Camphor

38. 1,7,7-trimethylbicyclo(2.2.1)heptan-2-one

39. Camphor Oil

40. Camphor Powder

41. Formosa

42. Bicyclo[2.2.1]heptan-2-one, 1,7,7-trimethyl-, (.+/-.)-

43. Japan Camphor

44. Camphor (usp)

45. Bicyclo[2.2.1]heptan-2-one, 1,7,7-trimethyl-, (1r)-

46. Racemic Camphor

47. Disperseyellow3

48. Dl-2-bornanone

49. Heet (salt/mix)

50. Dextro,laevo-camphor

51. Sarna (salt/mix)

52. (?)-camphor

53. Dl-camphor (jp17)

54. (.+/-.)-camphor

55. Camphor Powder - Synthetic

56. (1rs,4rs)-1,7,7-trimethylbicyclo(2.2.1)heptan-2-one

57. Dsstox_cid_10955

58. Dsstox_rid_78860

59. Dsstox_gsid_30955

60. Schembl16068

61. Camphor, (.+/-.)-

62. Mls001055495

63. Chembl15768

64. Divk1c_000724

65. Gtpl2422

66. Dtxsid5030955

67. Hms502e06

68. Kbio1_000724

69. Bicyclo[2.2.1]heptan-2-one, 1,7,7-trimethyl-, (1s)-

70. Ninds_000724

71. Hms2268a06

72. Hms3885j06

73. Hy-n0808

74. Tox21_200237

75. Bbl012963

76. Mfcd00074738

77. S3851

78. S4516

79. Stk803534

80. ( Inverted Exclamation Marka)-camphor

81. Akos000118728

82. Akos022060577

83. Ac-5284

84. Ccg-266237

85. Ccg-266238

86. Db14156

87. Lmpr0102120001

88. Un 2717

89. Cas-76-22-2

90. Idi1_000724

91. Ncgc00090681-05

92. Ncgc00090730-01

93. Ncgc00090730-02

94. Ncgc00090730-05

95. Ncgc00257791-01

96. Ac-15523

97. Smr000386909

98. Vs-03622

99. (1r,4r)-1,7,7-trimethylnorbornan-2-one

100. Db-051377

101. Db-056037

102. Db-070734

103. C1251

104. Cs-0009813

105. Ft-0607017

106. Ft-0607018

107. Ft-0608303

108. 4,7,7-trimethyl-3-bicyclo[2.2.1]heptanone

109. 1,7,7-trimethyl-bicyclo[2.2.1]heptan-6-one

110. C00809

111. C18369

112. D00098

113. E75814

114. 1,7,7-trimethyl-bicyclo[2.2.1]heptan-2-one

115. A838646

116. Q181559

117. Q-200784

118. W-109539

119. W-110530

120. (+/-)-1,7,7-trimethyl-bicyclo[2,2,1]heptane-2-one

121. F0001-0763

122. Z940713494

2.3 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 152.23 g/mol
Molecular Formula C10H16O
XLogP32.2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count1
Rotatable Bond Count0
Exact Mass152.120115130 g/mol
Monoisotopic Mass152.120115130 g/mol
Topological Polar Surface Area17.1 Ų
Heavy Atom Count11
Formal Charge0
Complexity217
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Therapeutic Uses

Anti-Infective Agents, Local

National Library of Medicine's Medical Subject Headings online file (MeSH, 2014); Available from, as of July 31, 2014: https://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?term=Camphor


It /SRP: was formerly/ used ... In humans for inflamed joints, sprains, and rheumatic and other inflammatory conditions such as colds in throat and chest. ... patient may feel improved /however/ inflammation is not affected.

Osol, A. (ed.). Remington's Pharmaceutical Sciences. 16th ed. Easton, Pennsylvania: Mack Publishing Co., 1980., p. 724


MEDICATION (VET): Locally, camphor is weakly antiseptic and has a rubefacient action when applied to skin. It is a common ingredient of many liniments.

Jones, L.M., et al. Veterinary Pharmacology & Therapeutics. 4th ed. Ames: Iowa State University Press, 1977., p. 414


MEDICATION (VET): /Camphor/ ... As a steam inhalant has been popular in respiratory diseases of horses and poultry. Orally, it has been popular in antiferment and carminative mixtures for calf scours, and in expectorant mixtures.

Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 74


For more Therapeutic Uses (Complete) data for CAMPHOR (10 total), please visit the HSDB record page.


4.2 Drug Warning

Keep pharmaceutical preparations and moth-repellents out of the reach of children and irresponsible people. Label camphorated oil appropriately to avoid mistaking it for castor oil and cough syrups. Do not place camphor ointments into infants' nostrils. Do not use the rubefacient on abraded skin.

IPCS; Poisons Information Monograph 095: Camphor. (Date of last update: May 1989). Available from, as of June 30, 2014: https://www.inchem.org/documents/pims/pharm/camphor.htm#SectionTitle:1.5%20Brand%20names,%20Trade%20na


Camphor and camphor containing products should be avoided in children who have a history of febrile convulsions or other predisposing factors for convulsions.

National Poisons Information Service Center, United Kingdom; Poisons Information Monograph: Camphor. (March 1996). Available from, as of June 30, 2014: https://www.inchem.org/documents/ukpids/ukpids/ukpid19.htm


Camphor should not be applied to the nostrils of infants even in small quantities, as this may cause immediate collapse.

SWEETMAN, S.C. (ed.) Martindale-The Complete Drug Reference. 36th ed. London: The Pharmaceutical Press, 2009., p. 2273


The UK Committee on the Review of Medicines recommended that camphor should not be included in products intended for the treatment of hepatic and biliary disorders, gallstones, colic, renal disorders, urinary tract infections, or ureteral stones. The use of camphor parenterally or as irrigants was considered undesirable due to the associated safety hazard.

SWEETMAN, S.C. (ed.) Martindale-The Complete Drug Reference. 36th ed. London: The Pharmaceutical Press, 2009., p. 2273


For more Drug Warnings (Complete) data for CAMPHOR (11 total), please visit the HSDB record page.


4.3 Minimum/Potential Fatal Human Dose

...fatalities in children have been recorded from 1g.

SWEETMAN, S.C. (ed.) Martindale-The Complete Drug Reference. 36th ed. London: The Pharmaceutical Press, 2009., p. 2273


...The literature from 1964-1983 /was reviewed/, and... the mean dose ingested by patients with major symptoms /was/ 124 mg/kg, with the mean dose in fatal cases being 199 mg/kg. /It was/... suggested, based on /the/ analysis of these figures, that patients ingesting <10 mg/kg of camphor and displaying no symptoms required no treatment. Adults have survived ingestions of up to 42 g, but usually doses in excess of 2 g produce dangerous effects. Fatal doses in children have ranged from 0.7-1.0 g.

National Poisons Information Service Center, United Kingdom; Poisons Information Monograph: Camphor. (March 1996). Available from, as of June 30, 2014: https://www.inchem.org/documents/ukpids/ukpids/ukpid19.htm


Dosages exceeding 2.0 grams have been reported to be /CNS depressant/ and may cause convulsions, delirium, hallucinations, and death.

McGuffin M, Hobbs C et al., eds; American Herbal Products Association's Botanical Safety Handbook. p. 31 (1997)


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anti-Infective Agents, Local

Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)


5.2 Absorption, Distribution and Excretion

Camphor is rapidly absorbed from the mucous membranes and the gastrointestinal tract. ... It is also absorbed through inhalation, through dermal application, and by nasal instillation.

Ford MD, Delaney KA, Ling LJ, Erickson T; Clinical Toxicology. W.B. Saunders Company., Philadelphia, PA. 2001, p. 339


... after camphor ingestion by mothers ... camphor was detectable in maternal blood 15 min after ingestion, but not after 8 hr. At delivery 36 hr later ... it was present in amnionic fluid, cord and fetal blood and fetal brain, liver and kidneys.

Gosselin, R.E., R.P. Smith, H.C. Hodge. Clinical Toxicology of Commercial Products. 5th ed. Baltimore: Williams and Wilkins, 1984., p. III-85


Alimentary absorption of pure camphor, or of alcohol solution ... is quite rapid, but from the oil preparation absorption is constant. Camphor is ... slowly absorbed from sc or im depots.

Thienes, C., and T.J. Haley. Clinical Toxicology. 5th ed. Philadelphia: Lea and Febiger, 1972., p. 16


Absorbed camphor is mainly eliminated as the oxidized camphorol in the urine, although some appears in the breath, sweat, and feces.

Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 74


For more Absorption, Distribution and Excretion (Complete) data for CAMPHOR (7 total), please visit the HSDB record page.


5.3 Metabolism/Metabolites

In the liver microsomes of female mice, two induction phases during inhalation of DL-camphor were found. During the first 24 hr the apparent molar activity of the ethylumbelliferone dealkylase decreased. In the second phase, the molar ethylumbelliferone dealkylase activity was constant.

Mohn G; Different phases of hydroxylase induction in liver microsomes of female mice during inhalation of cyclohexane and D,L-camphor; Microsomes Drug Oxid, Proc Int Symp, 3rd: 59-66 (1977)


The metabolism of (+)-camphor and (-)-camphor was investigated in rabbits after administration /through/ stomach tube; metabolites of (+)-camphor were (+)-borneol, (+)-5-endo-hydroxycamphor, and (+)-3-endohydroxycamphor.

ROBERTSON JS, HUSSAIN M; METABOLISM OF CAMPHORS AND RELATED COMPOUNDS; BIOCHEM J 113 (1): 57-65 (1969)


Camphor is rapidly oxidized to campherols (2-hydroxycamphor and 3-hydroxycamphor), and then conjugated in the liver to the glucuronide form. Camphor-related metabolites are relatively fat-soluble and may accumulate in fatty tissue.

IPCS; Poisons Information Monograph 095: Camphor. (Date of last update:May 1989). Available from, as of June 30, 2014: https://www.inchem.org/documents/pims/pharm/camphor.htm#SectionTitle:1.5%20Brand%20names,%20Trade%20na


5.4 Biological Half-Life

167 minutes (200 mg camphor ingested alone); 93 minutes (200 mg camphor ingested with a solvent - Tween 80).

National Poisons Information Service Center, United Kingdom; Poisons Information Monograph: Camphor. (March 1996). Available from, as of June 30, 2014: https://www.inchem.org/documents/ukpids/ukpids/ukpid19.htm


5.5 Mechanism of Action

Camphor is a naturally occurring compound that is used as a major active ingredient of balms and liniments supplied as topical analgesics. ... Capsaicin and menthol, two other topically applied agents widely used for similar purposes, are known to excite and desensitize sensory nerves by acting on two members of transient receptor potential (TRP) channel superfamily: heat-sensitive TRP vanilloid subtype 1 (TRPV1) and cold-sensitive TRP channel M8, respectively. Camphor has recently been shown to activate TRPV3, and here /investigators/ show that camphor also activates heterologously expressed TRPV1, requiring higher concentrations than capsaicin. Activation was enhanced by phospholipase C-coupled receptor stimulation mimicking inflamed conditions. Similar camphor-activated TRPV1-like currents were observed in isolated rat DRG neurons and were strongly potentiated after activation of protein kinase C with phorbol-12-myristate-13-acetate. Camphor activation of rat TRPV1 was mediated by distinct channel regions from capsaicin, as indicated by camphor activation in the presence of the competitive inhibitor capsazepine and in a capsaicin-insensitive point mutant. Camphor did not activate the capsaicin-insensitive chicken TRPV1. TRPV1 desensitization is believed to contribute to the analgesic actions of capsaicin. /The authors/ found that, although camphor activates TRPV1 less effectively, camphor application desensitized TRPV1 more rapidly and completely than capsaicin. Conversely, TRPV3 current sensitized after repeated camphor applications, which is inconsistent with the analgesic role of camphor. /Investigators/ also found that camphor inhibited several other related TRP channels, including ankyrin-repeat TRP 1 (TRPA1). The camphor-induced desensitization of TRPV1 and block of TRPA1 may underlie the analgesic effects of camphor.

PMID:16192383 Xu H et al; J Neurosci. 25(39):8924-37 (2005).


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Mangalam Organics Ltd

India

USDMF

arrow
PEGS Boston Summit
Not Confirmed

01

PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 42378

Submission : 2025-12-21

Status : Active

Type : IV

blank

02

Silverline Chemicals

India

USDMF

arrow
PEGS Boston Summit
Not Confirmed

02

PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 35026

Submission : 2020-08-26

Status : Active

Type : IV

blank

03

PEGS Boston Summit
Not Confirmed

03

04

Mangalam Organics Ltd

Country

USDMF

arrow
PEGS Boston Summit
Not Confirmed

04

Mangalam Organics Ltd

Country
arrow
PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 42354

Submission : 2025-10-28

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-moreread-more

01

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Certificate Number : R0-CEP 2021-044 - Rev 00

Status : Valid

Issue Date : 2023-01-27

Type : Chemical

Substance Number : 655

blank

SAPTAGIR LABORATORIES PRIVATE LIMIT...

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
CEP 2023-320 - Rev 00
Valid
Chemical
2026-03-17
655
blank

02

SAPTAGIR LABORATORIES PRIVATE LIMIT...

Country
PEGS Boston Summit
Not Confirmed
arrow

SAPTAGIR LABORATORIES PRIVATE LIMIT...

Country
arrow
PEGS Boston Summit
Not Confirmed

Certificate Number : CEP 2023-320 - Rev 00

Status : Valid

Issue Date : 2026-03-17

Type : Chemical

Substance Number : 655

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-moreread-more

01

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Japanese Pharmacopoeia dl-Camphor

Registration Number : 225MF10027

Registrant's Address : No. 85, Taqian Road, Huiyao Industrial Park, Jianyang District, Nanping City, Fujian ...

Initial Date of Registration : 2013-02-13

Latest Date of Registration : 2013-02-13

blank

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Japanese Pharmacopoeia d-Camphor

Registration Number : 217MF10184

Registrant's Address : 2-4-9 Bingomachi, Chuo-ku, Osaka City, Osaka Prefecture

Initial Date of Registration : 2005-06-06

Latest Date of Registration : 2006-10-20

blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Japanese Pharmacopoeia DL-Camphor

Registration Number : 224MF10085

Registrant's Address : Dongsha, Nanfeng Town, Zhangjiagang City, Jiangsu Province

Initial Date of Registration : 2012-04-13

Latest Date of Registration : 2012-04-13

blank

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Japanese Pharmacopoeia dl-Camphor (For manufacturing purposes only)

Registration Number : 228MF10069

Registrant's Address : No.1 Wusong Road, Wanxiu District, Wuzhou City

Initial Date of Registration : 2016-02-29

Latest Date of Registration : 2016-02-29

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Synthetic Camphor USP/Ph. Eur

Date of Issue : 2024-03-01

Valid Till : 2027-02-28

Written Confirmation Number : WC-0472

Address of the Firm : Sy. No. Parts of 27, 46 and 50 to 56, Ananthasagar (V), Chegunta (M), Medak (D),...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

CAMPHOR (SYNTHETIC)

NDC Package Code : 52330-002

Start Marketing Date : 2021-11-11

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

CAMPHOR (NATURAL)

NDC Package Code : 83631-001

Start Marketing Date : 2023-06-25

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

CAMPHOR (NATURAL)

NDC Package Code : 51551-0309

Start Marketing Date : 2023-06-25

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

CAMPHOR (SYNTHETIC)

NDC Package Code : 59599-120

Start Marketing Date : 2018-01-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

CAMPHOR (SYNTHETIC)

NDC Package Code : 58811-7622

Start Marketing Date : 2010-07-28

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

Privi Specialty Chemicals LTD.

Country
PEGS Boston Summit
Not Confirmed
arrow

Privi Specialty Chemicals LTD.

Country
arrow
PEGS Boston Summit
Not Confirmed

CAMPHOR (SYNTHETIC)

NDC Package Code : 84389-000

Start Marketing Date : 2024-07-11

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Flag U.S.A
Digital Content Digital Content

Camphor

About the Company : Rochem, established in 1994, is a global distributor of pharmaceutical, food, nutritional, and animal health ingredients, sourcing high-quality products from China. Headquartered i...

Rochem, established in 1994, is a global distributor of pharmaceutical, food, nutritional, and animal health ingredients, sourcing high-quality products from China. Headquartered in Hauppauge, New York, it operates 16 offices worldwide. Rochem’s operations are fully cGMP compliant and have been audited by the USFDA and several multinational organizations. The company also trains and audits its partners to ensure FDA-compliant technologies and systems. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Rochem

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharm-Rx is a reputed global importer and distributor of pharmaceutical active ingredients.

Flag U.S.A
Digital Content Digital Content

Camphor

About the Company : Established in 1991, Pharm-Rx is an importer and distributor of active ingredients serving the pharmaceutical, nutritional supplement, and food industries. The company follows a hi...

Established in 1991, Pharm-Rx is an importer and distributor of active ingredients serving the pharmaceutical, nutritional supplement, and food industries. The company follows a highly selective supplier qualification process, including direct visits to overseas manufacturers, to maintain high quality standards. Pharm-Rx’s growth is driven by a consistent focus on quality ingredients, competitive pricing, and customer service. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Pharm RX

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Camphor

About the Company : Saptagir Laboratories Private incorporated in 2016, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) and Intermediates for a wide range of therapeutic cat...

Saptagir Laboratories Private incorporated in 2016, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) and Intermediates for a wide range of therapeutic categories specifically focusing on Anti-Fungal and Anti-Platelets. Our vision is to attain market leadership in development of innovator molecules for the domestic and export market.
blank

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Camphor

About the Company : Swati Menthol and Allied Chemicals Ltd a Public Limited company at Rampur India (UP) and got established in 1978. one of the largest manufacturer and exporter menthol and allied p...

Swati Menthol and Allied Chemicals Ltd a Public Limited company at Rampur India (UP) and got established in 1978. one of the largest manufacturer and exporter menthol and allied products. As of date we are well known in the mint trade as a reliable source and long term supplier of multi products including Menthol Crystals (Food grade), Spearmint oil, Mentha Piperita (100% Natural and pure), DMO, Cornmint Oil, Mentha Arvensis, Natural Cis-3-Hexenol and its esters.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more
  • Development Update

Details:

Menthol, a miscellaneous product, targets TRPA1 and TRPM8 to address sprains.


Lead Product(s): Menthol,Camphor,Capsaicin

Therapeutic Area: Musculoskeletal Brand Name: Soothe Gel

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 18, 2025

blank

01

CBD Life Sciences

Country
arrow
PEGS Boston Summit
Not Confirmed

CBD Life Sciences

Country
arrow
PEGS Boston Summit
Not Confirmed

Details : Menthol, a miscellaneous product, targets TRPA1 and TRPM8 to address sprains.

Product Name : Soothe Gel

Product Type : Miscellaneous

Upfront Cash : Inapplicable

November 18, 2025

blank
  • Development Update

Details:

Analgesic is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Dysmenorrhea.


Lead Product(s): Analgesic,Camphor,Menthol

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Undisclosed

Sponsor: Citruslabs

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 23, 2025

blank

02

Rael

Country
arrow
PEGS Boston Summit
Not Confirmed

Rael

Country
arrow
PEGS Boston Summit
Not Confirmed

Details : Analgesic is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Dysmenorrhea.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

April 23, 2025

blank

Details:

The Company intends to use the net proceeds to fund the Company's pre-investigational new drug meeting regarding the human application of the Company's products, including Cannabidiol.


Lead Product(s): Cannabidiol,Camphor,Menthol

Therapeutic Area: Immunology Brand Name: LPT-CBD

Study Phase: UndisclosedProduct Type: Controlled Substance

Sponsor: Research Capital Corporation

Deal Size: $1.6 million Upfront Cash: Undisclosed

Deal Type: Private Placement October 20, 2023

blank

03

PEGS Boston Summit
Not Confirmed
PEGS Boston Summit
Not Confirmed

Details : The Company intends to use the net proceeds to fund the Company's pre-investigational new drug meeting regarding the human application of the Company's products, including Cannabidiol.

Product Name : LPT-CBD

Product Type : Controlled Substance

Upfront Cash : Undisclosed

October 20, 2023

blank

Details:

The Company intends to use the net proceeds from the Offering to fund the Company's pre-investigational new drug meeting with the United States FDA regarding the human application and expansion of the Company's derma-cosmetic product distribution.


Lead Product(s): Cannabidiol,Camphor,Menthol

Therapeutic Area: Neurology Brand Name: LPT-CBD

Study Phase: Approved FDFProduct Type: Controlled Substance

Sponsor: Research Capital Corporation

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Private Placement October 12, 2023

blank

04

PEGS Boston Summit
Not Confirmed
PEGS Boston Summit
Not Confirmed

Details : The Company intends to use the net proceeds from the Offering to fund the Company's pre-investigational new drug meeting with the United States FDA regarding the human application and expansion of the Company's derma-cosmetic product distribution.

Product Name : LPT-CBD

Product Type : Controlled Substance

Upfront Cash : Undisclosed

October 12, 2023

blank
  • Deals

Details:

The acquired asset supports Angelini Pharma reinforcing both its Consumer Healthcare business and consolidating its International presence.


Lead Product(s): Camphor,Capsicum Oleoresin,Menthol

Therapeutic Area: Neurology Brand Name: ThermaCare

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Angelini Pharma

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition March 10, 2020

blank

05

GSK

United Kingdom
arrow
PEGS Boston Summit
Not Confirmed

GSK

United Kingdom
arrow
PEGS Boston Summit
Not Confirmed

Details : The acquired asset supports Angelini Pharma reinforcing both its Consumer Healthcare business and consolidating its International presence.

Product Name : ThermaCare

Product Type : Miscellaneous

Upfront Cash : Undisclosed

March 10, 2020

blank
  • Development Update

Details:

Menthol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pain.


Lead Product(s): Menthol,Camphor

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Active and Innovative

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 07, 2019

blank

06

University of Toronto

Country
arrow
PEGS Boston Summit
Not Confirmed

University of Toronto

Country
arrow
PEGS Boston Summit
Not Confirmed

Details : Menthol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pain.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 07, 2019

blank

Details:

Guaiacol is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Cough.


Lead Product(s): Guaiacol,Eucalyptol,Menthol,Camphor

Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 07, 2010

blank

07

Azidus

Brazil
arrow
PEGS Boston Summit
Not Confirmed

Azidus

Brazil
arrow
PEGS Boston Summit
Not Confirmed

Details : Guaiacol is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Cough.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 07, 2010

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Topical

read-more
read-more

Solubilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Emulsifying Agents

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Lubricants & Glidants

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Co-Processed Excipients

read-more
read-more

Rheology Modifiers

read-more
read-more

API Stability Enhancers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 76-22-2 / Camphor API manufacturers, exporters & distributors?

Camphor manufacturers, exporters & distributors 1

35

PharmaCompass offers a list of Camphor API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Camphor manufacturer or Camphor supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Camphor manufacturer or Camphor supplier.

API | Excipient name

Camphor

Synonyms

76-22-2, 2-camphanone, Dl-camphor, (+/-)-camphor, 2-bornanone, 1,7,7-trimethylbicyclo[2.2.1]heptan-2-one

Cas Number

76-22-2

About Camphor

A bicyclic monoterpene ketone found widely in plants, especially CINNAMOMUM CAMPHORA. It is used topically as a skin antipruritic and as an anti-infective agent.

Camphor USP Manufacturers

A Camphor USP manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Camphor USP, including repackagers and relabelers. The FDA regulates Camphor USP manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Camphor USP API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Camphor USP manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Camphor USP Suppliers

A Camphor USP supplier is an individual or a company that provides Camphor USP active pharmaceutical ingredient (API) or Camphor USP finished formulations upon request. The Camphor USP suppliers may include Camphor USP API manufacturers, exporters, distributors and traders.

click here to find a list of Camphor USP suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Camphor USP USDMF

A Camphor USP DMF (Drug Master File) is a document detailing the whole manufacturing process of Camphor USP active pharmaceutical ingredient (API) in detail. Different forms of Camphor USP DMFs exist exist since differing nations have different regulations, such as Camphor USP USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Camphor USP DMF submitted to regulatory agencies in the US is known as a USDMF. Camphor USP USDMF includes data on Camphor USP's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Camphor USP USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Camphor USP suppliers with USDMF on PharmaCompass.

Camphor USP JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Camphor USP Drug Master File in Japan (Camphor USP JDMF) empowers Camphor USP API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Camphor USP JDMF during the approval evaluation for pharmaceutical products. At the time of Camphor USP JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Camphor USP suppliers with JDMF on PharmaCompass.

Camphor USP CEP

A Camphor USP CEP of the European Pharmacopoeia monograph is often referred to as a Camphor USP Certificate of Suitability (COS). The purpose of a Camphor USP CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Camphor USP EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Camphor USP to their clients by showing that a Camphor USP CEP has been issued for it. The manufacturer submits a Camphor USP CEP (COS) as part of the market authorization procedure, and it takes on the role of a Camphor USP CEP holder for the record. Additionally, the data presented in the Camphor USP CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Camphor USP DMF.

A Camphor USP CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Camphor USP CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Camphor USP suppliers with CEP (COS) on PharmaCompass.

Camphor USP WC

A Camphor USP written confirmation (Camphor USP WC) is an official document issued by a regulatory agency to a Camphor USP manufacturer, verifying that the manufacturing facility of a Camphor USP active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Camphor USP APIs or Camphor USP finished pharmaceutical products to another nation, regulatory agencies frequently require a Camphor USP WC (written confirmation) as part of the regulatory process.

click here to find a list of Camphor USP suppliers with Written Confirmation (WC) on PharmaCompass.

Camphor USP NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Camphor USP as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Camphor USP API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Camphor USP as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Camphor USP and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Camphor USP NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Camphor USP suppliers with NDC on PharmaCompass.

Camphor USP GMP

Camphor USP Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Camphor USP GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Camphor USP GMP manufacturer or Camphor USP GMP API supplier for your needs.

Camphor USP CoA

A Camphor USP CoA (Certificate of Analysis) is a formal document that attests to Camphor USP's compliance with Camphor USP specifications and serves as a tool for batch-level quality control.

Camphor USP CoA mostly includes findings from lab analyses of a specific batch. For each Camphor USP CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Camphor USP may be tested according to a variety of international standards, such as European Pharmacopoeia (Camphor USP EP), Camphor USP JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Camphor USP USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty